DK3191464T3 - Syntese af isoflavaner og intermediater deraf - Google Patents
Syntese af isoflavaner og intermediater deraf Download PDFInfo
- Publication number
- DK3191464T3 DK3191464T3 DK15762559.1T DK15762559T DK3191464T3 DK 3191464 T3 DK3191464 T3 DK 3191464T3 DK 15762559 T DK15762559 T DK 15762559T DK 3191464 T3 DK3191464 T3 DK 3191464T3
- Authority
- DK
- Denmark
- Prior art keywords
- isoflavanes
- intermediates
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14184240 | 2014-09-10 | ||
| PCT/EP2015/070544 WO2016038061A1 (en) | 2014-09-10 | 2015-09-09 | Synthesis of isoflavanes and intermediates thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3191464T3 true DK3191464T3 (da) | 2020-02-03 |
Family
ID=51492886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15762559.1T DK3191464T3 (da) | 2014-09-10 | 2015-09-09 | Syntese af isoflavaner og intermediater deraf |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10030003B2 (da) |
| EP (1) | EP3191464B1 (da) |
| JP (1) | JP6744860B2 (da) |
| KR (1) | KR102514781B1 (da) |
| CN (1) | CN106795135B (da) |
| AU (1) | AU2015314313B2 (da) |
| CA (1) | CA2960437C (da) |
| DK (1) | DK3191464T3 (da) |
| WO (1) | WO2016038061A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114507645A (zh) * | 2020-11-16 | 2022-05-17 | 艾博锐克生物科技(山东)有限公司 | 一类新型黄酮还原酶及其应用 |
| WO2024040267A2 (en) * | 2022-08-19 | 2024-02-22 | Mitokinin, Inc. | Direct synthesis of n-(3-substituted-chroman-4-yl)-7h- pyrrolo[2,3-d]pyrimidin-4-amines and derivatives thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1025850B1 (en) | 1997-08-08 | 2005-11-23 | Otsuka Pharmaceutical Co., Ltd. | Isoflavone-containing compositions |
| AU2002952453A0 (en) * | 2002-11-01 | 2002-11-21 | Novogen Research Pty Ltd | Aminated isoflavonoid derivatives and uses thereof |
| US7528267B2 (en) * | 2005-08-01 | 2009-05-05 | Girindus America, Inc. | Method for enantioselective hydrogenation of chromenes |
| US7696363B2 (en) | 2005-12-02 | 2010-04-13 | Yasoo Health Inc. | Preparation of flavonoid compounds |
| EP2154133A1 (de) * | 2008-08-14 | 2010-02-17 | System Biologie AG | Synthese von Equol |
| WO2010141805A1 (en) | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Heterocyclic amides as modulators of trpa1 |
| CN102925378B (zh) * | 2012-05-11 | 2014-06-04 | 华侨大学 | 一种奇异变形杆菌菌株及其转化大豆苷元生产s-雌马酚的方法 |
-
2015
- 2015-09-09 EP EP15762559.1A patent/EP3191464B1/en active Active
- 2015-09-09 US US15/507,371 patent/US10030003B2/en active Active
- 2015-09-09 DK DK15762559.1T patent/DK3191464T3/da active
- 2015-09-09 JP JP2017512002A patent/JP6744860B2/ja active Active
- 2015-09-09 CN CN201580048335.3A patent/CN106795135B/zh active Active
- 2015-09-09 CA CA2960437A patent/CA2960437C/en active Active
- 2015-09-09 KR KR1020177009541A patent/KR102514781B1/ko active IP Right Grant
- 2015-09-09 WO PCT/EP2015/070544 patent/WO2016038061A1/en active Application Filing
- 2015-09-09 AU AU2015314313A patent/AU2015314313B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2960437C (en) | 2022-12-13 |
| US20170283389A1 (en) | 2017-10-05 |
| US10030003B2 (en) | 2018-07-24 |
| AU2015314313B2 (en) | 2019-09-19 |
| KR20170054461A (ko) | 2017-05-17 |
| CN106795135B (zh) | 2019-08-09 |
| CA2960437A1 (en) | 2016-03-17 |
| JP6744860B2 (ja) | 2020-08-19 |
| KR102514781B1 (ko) | 2023-03-28 |
| CN106795135A (zh) | 2017-05-31 |
| EP3191464B1 (en) | 2019-11-06 |
| WO2016038061A1 (en) | 2016-03-17 |
| EP3191464A1 (en) | 2017-07-19 |
| JP2017528456A (ja) | 2017-09-28 |
| AU2015314313A1 (en) | 2017-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3137169T3 (da) | Hæmmere af lysin-specifik demethylase-1 | |
| DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
| DK3180331T3 (da) | Polymorfer af selinexor | |
| DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
| DK3851537T3 (da) | Behandling af hyperbilirubinæmi | |
| DK3511319T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
| DK3102555T3 (da) | Sammensætninger af forbindelser og anvendelser deraf | |
| DK3288553T3 (da) | Kombinationer af cannabinoider og n-acylethanolaminer | |
| DK3448846T3 (da) | Syntese af indazoler | |
| DK3215493T3 (da) | Syntese af copanlisib og dihydrochloridsalt deraf | |
| DK3099800T3 (da) | Ekspression og oprensning af crm197 og beslægtede proteiner | |
| DK3514109T3 (da) | Hydropyrolyse af biomasseholdige råmaterialer | |
| DK3448849T3 (da) | Syntese af indazoler | |
| DK3237621T3 (da) | Varianter af human alpha-galactosidase | |
| DK3389669T3 (da) | Triterpensaponinvarianter, syntesefremgangsmåder og anvendelse deraf | |
| DK3204352T3 (da) | Hæmmere af lysin-gingipain | |
| DK3297619T3 (da) | Terapeutiske anvendelser af L-4-chlorkynurenin | |
| DK3529236T3 (da) | Krystalformer af eravacyclin | |
| DK3209677T3 (da) | Varianter af gal2-transporter og anvendelser deraf | |
| DK3418273T3 (da) | Derivater af flavagliner | |
| DK3511000T3 (da) | Krystallinsk form x2 af grapiprant | |
| DK3430004T3 (da) | Faststofformer af nilotinibsalte | |
| DK3113774T3 (da) | Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf | |
| ZA201701976B (en) | Synthesis of ent-progesterone and intermediates thereof |